Institute of Arthritis Research Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2020
NCT04424693
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Institute of Arthritis Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diphtheria (Phase 4)

Eclampsia (Phase 4)

Pre-Eclampsia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1